Asayut Narong, Sookaneknun Phayom, Chaiyasong Surasak, Saramunee Kritsanee
Doctor of Philosophy in Pharmacy Program, Mahasarakham University, Kantharawichai, Thailand.
Primary Care Practice Research Unit, Kantharawichai, Thailand.
Int J Pharm Pract. 2018 Feb;26(1):16-27. doi: 10.1111/ijpp.12385. Epub 2017 Aug 9.
Identify costs, outcomes and stakeholders' perspectives associated with incorporation of community pharmacy services into the Thai National Health Insurance System and their values to all stakeholders.
Using a combination of search terms, a comprehensive literature search was performed using the Thai Journal Citation Index Centre, Health System Research Institute database, PubMed and references from recent reviews. Identified studies were published between January 2000 and December 2014. The review included publications in English and Thai on primary research undertaken in community pharmacies associated with the National Health Insurance System. Two independent authors performed study selection, data extraction and quality assessment.
The literature search yielded 251 titles, with 18 satisfying the inclusion criteria. Clinical outcomes of community pharmacy services included control and reduction in blood pressure and blood sugar, improved adherence to medications, an increase in acceptance of interventions, and an increase in healthy behaviours. Thirty-three percentage of those at risk of diabetes and hypertension achieved normal blood sugar and blood pressure levels after being followed for 2-6 months by a community pharmacist. The cost of collaborative screening by community pharmacies and primary care units was US$ 4.5. Diabetes management costs were US$ 5.1-30.7. Community pharmacists reported high satisfaction rates. Stakeholders' perspectives revealed support for the community pharmacists' roles and the inclusion of community pharmacies as partners with the National Health Insurance System.
Community pharmacy services improved outcomes for diabetic and hypertensive patients. This review supports the feasibility of incorporating community pharmacies into the Thai National Health System.
确定与将社区药房服务纳入泰国国家健康保险系统相关的成本、结果及利益相关者的观点，以及这些对所有利益相关者的价值。
通过组合搜索词，利用泰国期刊引文索引中心、卫生系统研究所数据库、PubMed以及近期综述的参考文献进行全面的文献检索。纳入的研究发表于2000年1月至2014年12月之间。该综述涵盖了关于与国家健康保险系统相关的社区药房进行的初步研究的英文和泰文出版物。两名独立作者进行了研究选择、数据提取和质量评估。
文献检索共得到251个标题，其中18个符合纳入标准。社区药房服务的临床结果包括血压和血糖得到控制和降低、药物依从性提高、干预接受度增加以及健康行为增多。社区药剂师对有糖尿病和高血压风险的人群进行2至6个月的随访后，33%的人血糖和血压水平恢复正常。社区药房与基层医疗单位联合筛查的成本为4.5美元。糖尿病管理成本为5.1至30.7美元。社区药剂师报告的满意度较高。利益相关者的观点显示出对社区药剂师角色的支持，以及将社区药房纳入作为国家健康保险系统合作伙伴的支持。
社区药房服务改善了糖尿病和高血压患者的治疗效果。本综述支持将社区药房纳入泰国国家卫生系统的可行性。
